Economic evaluation of mental health promotion and mental illness prevention

Economic evaluation is a conglomerate of methods that aim to make explicit the costs and consequences of competing healthcare programmes, and the interconnections between them, so that different interventions can be compared in terms of their value-for-money. In this chapter we outline the main building blocks of health economic evaluation, we explain the differences between the prevailing techniques and we discuss their application in the context of mental health promotion and mental illness prevention.

[1]  B. Weisbrod,et al.  Alternative to mental hospital treatment. II. Economic benefit-cost analysis. , 1980, Archives of general psychiatry.

[2]  P. Dolan,et al.  Distributing Health Care: Economic and Ethical Issues , 2003 .

[3]  Joshua T. Cohen,et al.  Does preventive care save money? Health economics and the presidential candidates. , 2008, The New England journal of medicine.

[4]  M. Barkham,et al.  Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D , 2014, British Journal of Psychiatry.

[5]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[6]  M. Weinstein,et al.  QALYs: the basics. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[7]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[8]  M. Knapp,et al.  Parenting interventions for the prevention of persistent conduct disorder in Mental health promotion and mental illness prevention: the economic case , 2011 .

[9]  B. O'brien,et al.  Willingness to Pay , 1994, Medical decision making : an international journal of the Society for Medical Decision Making.

[10]  Jing Jing Li,et al.  Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. , 2009, JAMA.

[11]  S. Morris,et al.  Cost of depression among adults in England in 2000. , 2003, The British journal of psychiatry : the journal of mental science.

[12]  J. Luyten,et al.  Costing Infectious Disease Outbreaks for Economic Evaluation , 2012, PharmacoEconomics.

[13]  N. Devlin,et al.  The Influence of Cost-Effectiveness and Other Factors on NICE Decisions , 2010, Health economics.

[14]  H. Naci,et al.  Economic evaluation of mental health interventions: an introduction to cost-utility analysis , 2016, Evidence-Based Mental Health.

[15]  Jordan J. Louviere,et al.  Applied Methods of Cost-Benefit Analysis in Health Care , 2010 .

[16]  Martin Knapp,et al.  Decision making by NICE: examining the influences of evidence, process and context , 2013, Health Economics, Policy and Law.

[17]  M. Knapp,et al.  QALYs and mental health care , 1997, Social Psychiatry and Psychiatric Epidemiology.

[18]  Julie Ratcliffe,et al.  Measuring and valuing health benefits for economic evaluation in adolescence: an assessment of the practicality and validity of the child health utility 9D in the Australian adolescent population. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[19]  P. Dolan.  The measurement of health-related quality of life , 2000 .

[20]  M. Pauly.  Valuing health care: Valuing health care benefits in money terms , 1995 .

[21]  Robert M. Kaplan.  Valuing health care: Utility assessment for estimating quality-adjusted life years , 1995 .